INFACARE PHARMACEUTICAL CORP — Form D
INFACARE PHARMACEUTICAL CORP of TREVOSE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-07. The offering totals $11.0M, of which $3.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-06-07
- Form: D
- Accession: 0001174264-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $11.0M
- Amount sold: $3.5M
- Remaining: $7.5M
- Investors: 11
- Date of first sale: 2017-05-24
- Revenue range: Decline to Disclose
- SEC file number: 021-288227
Issuer
- Name: INFACARE PHARMACEUTICAL CORP
- CIK: 0001174264
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 8 NESHAMINY INTERPLEX, SUITE 221, TREVOSE, PA, 19053
- Phone: 267-515-5850
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Peter Barrett | Director | Palo Alto, CA |
| Dan Burns | Director | Phoenix, AZ |
| William Crouse | Director | Malvern, PA |
| Patrick Enright | Director | Menlo Park, CA |
| Robert Vukovich | Director | Trevose, PA |
| Harold Werner | Director | Trevose, PA |
| Dan Burns | Executive Officer | Phoenix, AZ |
| E. Ronald Goldfuss | Executive Officer | Trevose, PA |
| Ron Goldfuss | Executive Officer | Trevose, PA |
| Richard Vietor | Director | Trevose, PA |
Other filings by this issuer (5)
More